Reportlinker Adds European Markets for Interventional Cardiology Devices 2011 (15 Countries)
NEW YORK, April 7, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
European Markets for Interventional Cardiology Devices 2011 (15 Countries)
In 2010, the European markets for interventional cardiology devices were valued at over euro1.5 billion. In 2010, the fastest growing European market for interventional cardiology devices as the United Kingdom. Over the forecast period, Scandinavia is expected to be the fastest growing market in Europe because it has relatively low DES penetration rates; as these penetration rates increase, they will boost market growth. Growth in countries such as Austria, France, and Switzerland are expected to slow over the forecast period due to decreases in prices across several device markets.
The European markets, as defined in this report, include:
- Germany,
- France,
- The United Kingdom (U.K.),
- Italy,
- Spain,
- Benelux (Belgium, Netherlands, and Luxembourg),
- Scandinavia (Finland, Denmark, Sweden, and Norway),
- Portugal,
- Austria and
- Switzerland
The interventional cardiology market includes:
- Drug-eluting stents,
- Bare-metal stents,
- PTCA balloon catheters,
- Interventional coronary catheters and guidewires,
- Diagnostic coronary catheters and guidewires,
- Coronary introducer sheaths,
- Embolic protection devices,
- Atherectomy devices,
- Coronary vascular closure devices,
- Optical coherence tomography (OCT) catheters
- Intravascular ultrasound (IVUS) catheters
In addition, this report covers the emerging markets for vulnerable plaque screening and treatment.
Within the European interventional cardiology market, companies such as Boston Scientific, Abbott Laboratories, Cordis and Medtronic lead the market, among many others. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2017, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios.
The executive summary of this report is also available for purchase.
TABLE OF CONTENTS
TABLE OF CONTENTS.I
LIST OF FIGURES.IX
LIST OF CHARTS.XXII
EXECUTIVE SUMMARY 1
1.1 EUROPEAN INTERVENTIONAL CARDIOLOGY DEVICE MARKETS. 1
1.2 TREND ANALYSIS BY COUNTRY.. 2
1.3 PROCEDURE NUMBERS . 3
1.4 COUNTRY PROFILE . 4
1.4.1 Population 4
1.4.2 GDP per Capita 4
1.4.3 PCI and DES Penetration Rates .. 4
1.4.4 Price Index.. 4
1.5 BARE-METAL AND DRUG-ELUTING STENT MARKET 6
1.6 PTCA BALLOON CATHETER MARKET . 7
1.7 INTERVENTIONAL CORONARY CATHETER MARKET . 7
1.8 INTERVENTIONAL CORONARY GUIDEWIRE MARKET 7
1.9 CORONARY INTRODUCER SHEATH MARKET. 8
1.10 CORONARY EMBOLIC PROTECTION DEVICE MARKET .. 8
1.11 CORONARY ATHERECTOMY DEVICE MARKET.. 9
1.12 DIAGNOSTIC CORONARY CATHETER AND GUIDEWIRE MARKET.. 10
1.13 FRACTIONAL FLOW RESERVE (FFR) GUIDEWIRE MARKET . 11
1.14 INTRAVASCULAR ULTRASOUND (IVUS) CATHETER MARKET 11
1.15 CORONARY VASCULAR CLOSURE DEVICE (VCD)MARKET 12
1.16 OPTICAL COHERENCE TOMOGRAPHY (OCT) DEVICE MARKET. 13
1.17 VULNERABLE PLAQUE DEVICE MARKET .. 14
1.18 COMPETITIVE ANALYSIS 14
RESEARCH METHODOLOGY 16
2.1 RESEARCH SCOPE . 16
2.2 IDATA'S 9-STEP METHODOLOGY . 16
Step 1: Project Initiation & Team Selection . 17
Step 2: Prepare Data Systems and Perform Secondary Research. 18
Step 3: Preparation for Interviews & Questionnaire Design 19
Step 4: Performing Primary Research.. 20
Step 5: Research Analysis: Establishing Baseline Estimates 22
Step 6: Market Forecast and Analysis .. 23
Step 7: Identify Strategic Opportunities . 25
Step 8: Final Review and Market Release . 26
Step 9: Customer Feedback and Market Monitoring 26
EUROPEAN INTERVENTIONAL CARDIOLOGY DEVICE MARKETS . 28
3.1 INTRODUCTION .. 28
3.1.1 Population at Risk. 28
3.2 CURRENCY EXCHANGE RATE. 30
3.3MARKET OVERVIEW 31
3.4MARKET BY SEGMENT 34
3.5MARKET BY COUNTRY .. 41
3.5.1.1 Germany 41
3.5.1.2 France.41
3.5.1.3 United Kingdom.41
3.5.1.4 Italy..42
3.5.1.5 Spain 42
3.5.1.6 Benelux ..42
3.5.1.7 Scandinavia .43
3.5.1.8 Portugal .43
3.5.1.9 Austria 43
3.5.1.10 Switzerland 43
3.6 TREND ANALYSIS BY COUNTRY 46
3.7MARKET DRIVERS AND LIMITERS 49
3.7.1 Market Drivers 49
3.7.2 Market Limiters.. 49
3.8 COMPETITIVE ANALYSIS .. 51
3.9MERGERS AND ACQUISITIONS 56
PROCEDURE NUMBERS. 57
4.1 TOTAL PROCEDURE NUMBERS .. 57
4.2 GERMANY. 62
4.3 FRANCE.. 63
4.4 UNITED KINGDOM 64
4.5 ITALY .. 65
4.6 SPAIN .. 66
4.7 BENELUX .. 67
4.8 SCANDINAVIA . 68
4.9 PORTUGAL 69
4.10 AUSTRIA . 70
4.11 SWITZERLAND.. 71
COUNTRY PROFILES 72
5.1 INTRODUCTION .. 72
5.1.1 Population. 72
5.1.2 GDP per Capita . 72
5.1.3 PCI and DES Penetration Rates 72
5.1.4 Price Index 73
5.2 GERMANY. 74
5.3 FRANCE.. 75
5.4 UNITED KINGDOM 76
5.5 ITALY .. 77
5.6 SPAIN .. 78
5.7 BENELUX .. 79
5.8 SCANDINAVIA . 80
5.9 PORTUGAL 81
5.10 AUSTRIA . 82
5.11 SWITZERLAND.. 83
CORONARY STENT MARKET 84
6.1 INTRODUCTION .. 84
6.2MARKET OVERVIEW 86
6.3MARKET ANALYSIS AND FORECAST .. 93
6.3.1 Total Coronary Stent Market.. 93
6.3.2 Drug-Eluting Stent Market 101
6.3.3 Bare-Metal Stent Market 109
6.4MARKET DRIVERS AND LIMITERS . 117
6.4.1 Drug-Eluting Stent Market 117
6.4.1.1 Market Drivers.117
6.4.1.2 Market Limiters ..117
6.4.2 Bare-Metal Stent Markets.. 119
6.4.2.1 Market Drivers.119
6.4.2.2 Market Limiters ..119
6.5 COMPETITIVE ANALYSIS 121
6.5.1 Emerging Competitors. 128
6.5.2 Bioabsorbable Coronary Stents.. 130
6.5.3 Bifurcated Coronary Stents .. 134
PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY BALLOON
CATHETER MARKET. 137
7.1 INTRODUCTION 137
7.1.1 Balloon Types .. 137
7.1.2 Drug-Eluting Balloons. 138
7.2MARKET ANALYSIS AND FORECAST 139
7.3 PROCEDURES. 147
7.3.1 Units per Procedure.. 147
7.3.2 Units Sold by Indication . 148
7.4MARKET DRIVERS AND LIMITERS . 151
7.4.1 Market Drivers. 151
7.4.2 Market Limiters 151
7.5 COMPETITIVE ANALYSIS 152
INTERVENTIONAL CORONARY CATHETER MARKET.. 156
8.1 INTRODUCTION 156
8.1.1 Units per Procedure.. 157
TABLE OF CONTENTS
© iData Research Inc., 2011 www.idataresearch.net v
8.2MARKET ANALYSIS AND FORECAST 158
8.3MARKET DRIVERS AND LIMITERS . 166
8.3.1 Market Drivers. 166
8.3.2 Market Limiters 166
8.4 COMPETITIVE ANALYSIS 168
INTERVENTIONAL CORONARY GUIDEWIRE MARKET 172
9.1 INTRODUCTION 172
9.1.1 Device Construction . 172
9.1.2 Hydrophilic Guidewires.. 173
9.1.3 Units per Procedure.. 173
9.2MARKET ANALYSIS AND FORECAST 174
9.3MARKET DRIVERS AND LIMITERS . 182
9.3.1 Market Drivers. 182
9.3.2 Market Limiters 182
9.4 COMPETITIVE ANALYSIS 184
CORONARY INTRODUCER SHEATH MARKET.. 188
10.1 INTRODUCTION . 188
10.1.1 The Femoral Approach. 189
10.1.2 Radial/Brachial Approach.. 189
10.2MARKET OVERVIEW.. 190
10.2.1 Units per Procedure 196
10.2.2 Coronary Introducer Sheath Market by Access Site.. 197
10.3MARKET ANALYSIS AND FORECAST . 200
10.3.1 Total Coronary Introducer Sheath Market . 200
10.3.2 Standard Coronary Introducer Sheath Market. 208
10.3.3 Coronary Micro-Introducer Sheath Market .. 216
10.4MARKET DRIVERS AND LIMITERS .. 224
10.4.1 Market Drivers.. 224
10.4.2 Market Limiters. 224
10.5 COMPETITIVE ANALYSIS . 226
CORONARY EMBOLIC PROTECTION DEVICE MARKET . 229
11.1 INTRODUCTION . 229
11.1.1 Saphenous Vein Grafts.. 229
11.1.2 Protection Mechanism .. 230
11.2MARKET ANALYSIS AND FORECAST . 231
11.3MARKET DRIVERS AND LIMITERS .. 240
11.3.1 Market Drivers.. 240
11.3.2 Market Limiters. 241
11.4 COMPETITIVE ANALYSIS . 242
CORONARY ATHERECTOMY DEVICE MARKET. 245
12.1 INTRODUCTION . 245
12.1.1 Atherectomy 245
12.1.2 Device Technologies .. 246
12.1.2.1 Mechanical Atherectomy .246
12.1.2.2 Laser Atherectomy ..246
12.1.2.3 Directional Coronary Atherectomy (DCA).246
12.2MARKET ANALYSIS & FORECAST .. 247
12.3MARKET DRIVERS AND LIMITERS .. 255
12.3.1 Market Drivers.. 255
12.3.2 Market Limiters. 256
12.4 COMPETITIVE ANALYSIS . 257
DIAGNOSTIC CORONARY CATHETER AND GUIDEWIRE MARKET.. 260
13.1 INTRODUCTION . 260
13.2MARKET OVERVIEW.. 261
13.3MARKET ANALYSIS AND FORECAST . 268
13.3.1 Total Diagnostic Coronary Catheter and Guidewire Market 268
13.3.2 Diagnostic Catheter Market .. 275
13.3.3 Diagnostic Guidewire Market 283
13.4MARKET DRIVERS AND LIMITERS .. 291
13.4.1 Market Drivers.. 291
13.4.2 Market Limiters. 291
13.5 COMPETITIVE ANALYSIS . 293
FRACTIONAL FLOW RESERVE GUIDEWIRE MARKET . 298
14.1 INTRODUCTION . 298
14.2MARKET ANALYSIS AND FORECAST . 299
14.3MARKET DRIVERS AND LIMITERS .. 307
14.3.1 Market Drivers.. 307
14.3.2 Market Limiters. 307
14.4 COMPETITIVE ANALYSIS . 308
CORONARY VASCULAR CLOSURE DEVICE MARKET 311
15.1 INTRODUCTION . 311
15.1.1 Invasive and Non-Invasive Devices 311
15.2MARKET OVERVIEW.. 312
15.3MARKET ANALYSIS AND FORECAST . 319
15.3.1 Total Coronary VCD Market. 319
15.3.2 Total Coronary VCD Market by Access Site . 327
15.3.3 Invasive Coronary VCD Market .. 329
15.3.4 Non-Invasive Coronary VCD Market 337
15.4MARKET DRIVERS AND LIMITERS .. 345
15.4.1 Market Drivers.. 345
15.4.2 Market Limiters. 345
15.5 COMPETITIVE ANALYSIS . 347
INTRAVASCULAR ULTRASOUND CATHETER MARKET.. 351
16.1 INTRODUCTION . 351
16.1.1 Pre-Stenting Applications 351
16.1.2 Post-Stenting Applications.. 352
16.1.3 IVUS Console Penetration.. 352
16.2MARKET ANALYSIS AND FORECAST . 353
16.3 PENETRATION RATE .. 361
16.4MARKET DRIVERS AND LIMITERS .. 362
16.4.1 Market Drivers.. 362
16.4.2 Market Limiters. 363
16.5 COMPETITIVE ANALYSIS . 364
OPTICAL COHERENCE TOMOGRAPHY CATHETER MARKET.. 367
17.1 INTRODUCTION . 367
17.1.1 OCT Applications 368
17.2MARKET ANALYSIS AND FORECAST . 370
17.3 PENETRATION RATE .. 378
17.4MARKET DRIVERS AND LIMITERS .. 379
17.4.1 Market Drivers.. 379
17.4.2 Market Limiters. 380
17.5 COMPETITIVE ANALYSIS . 381
VULNERABLE PLAQUE DEVICE MARKET 383
18.1 INTRODUCTION . 383
18.1.1 Vulnerable Plaque Screening Technologies .. 384
18.1.1.1 Intravascular Ultrasound (IVUS) 384
18.1.1.2 Optical Coherence Tomography (OCT) ..384
18.1.1.3 Raman Spectroscopy..385
18.1.1.4 Near Infrared (NIR) Spectroscopy..385
18.1.1.5 Thermography385
18.1.1.6 Intravascular Magnetic Resonance Imaging (IVMRI) .385
18.1.1.7 Computed Tomography (CT).386
18.1.2 Potential Vulnerable Plaque Treatments. 386
18.1.2.1 Stents..386
18.1.2.2 Pharmaceuticals ..386
18.1.2.3 Photodynamic Therapies .387
18.1.2.4 Cryotherapy 387
18.2 TARGET POPULATION 388
18.3MARKET ANALYSIS AND FORECAST . 391
18.3.1 Total Potential Market.. 391
18.3.2 Potential Vulnerable Plaque Screening Market .. 394
18.3.3 Potential Vulnerable Plaque Treatment Market.. 399
18.4MARKET DRIVERS AND LIMITERS .. 403
18.4.1 Market Drivers.. 403
18.4.2 Market Limiters. 403
18.5 COMPETITIVE ANALYSIS . 404
18.5.1 Past Companies and Technology. 407
ABBREVIATIONS 409
LIST OF FIGURES
EXECUTIVE SUMMARY 1
RESEARCH METHODOLOGY.. 16
EUROPEAN INTERVENTIONAL CARDIOLOGY DEVICE MARKETS 28
Figure 3-1: Exchange Rates for the Euro (euro), 2010. 30
Figure 3-2: Interventional Cardiology Device Markets, Europe, 2007 – 2017. 32
Figure 3-3: Interventional Cardiology Device Markets Segmented by Device
Type, Europe, 2007 – 2017 (euroM) (Part 1 of 2) .. 35
Figure 3-4: Interventional Cardiology Device Markets Segmented by Device
Type, Europe, 2007 – 2017 (US$M) (Part 1 of 2).. 37
Figure 3-5: Interventional Cardiology Device Markets Segmented by Device
Type, Europe, 2007 – 2017 (US$M) (Part 2 of 2).. 38
Figure 3-6: Interventional Cardiology Device Markets by Country, Europe,
2007 – 2017 (euroM) 44
Figure 3-7: Interventional Cardiology Markets by Country, Europe, 2007 – 2017
(US$M) 45
Figure 3-8: Interventional Cardiology Device Markets Growth Rates by Country,
Europe, 2007 – 2017 .. 47
Figure 3-9: Drivers and Limiters, Interventional Cardiology Device Markets,
Europe, 2010 . 50
Figure 3-10: Leading Competitors, Interventional Cardiology Device Markets,
Europe, 2010 (Part 1 of 2) 53
Figure 3-11: Leading Competitors, Interventional Cardiology Device Markets,
Europe, 2010 (Part 2 of 2) 54
PROCEDURE NUMBERS. 57
Figure 4-1: Angioplasty Procedures, Europe, 2007 – 2017 . 58
Figure 4-2: Angiography Procedures, Europe, 2007 – 2017 .. 60
Figure 4-3: Angioplasty and Angiography Procedures, Germany, 2007 – 2017.. 62
Figure 4-4: Angioplasty and Angiography Procedures, France, 2007 – 2017 .. 63
Figure 4-5: Angioplasty and Angiography Procedures, U.K., 2007 – 2017 .. 64
Figure 4-6: Angioplasty and Angiography Procedures, Italy, 2007 – 2017 .. 65
Figure 4-7: Angioplasty and Angiography Procedures, Spain, 2007 – 2017. 66
Figure 4-8: Angioplasty and Angiography Procedures, Benelux, 2007 – 2017 67
Figure 4-9: Angioplasty and Angiography Procedures, Scandinavia, 2007 – 2017 68
Figure 4-10: Angioplasty and Angiography Procedures, Portugal, 2007 – 2017. 69
Figure 4-11: Angioplasty and Angiography Procedures, Austria, 2007 – 2017 .. 70
Figure 4-12: Angioplasty and Angiography Procedures, Switzerland,
2007 – 2017 71
COUNTRY PROFILES .. 72
Figure 5-1: Country Indicators, 2010 73
CORONARY STENT MARKET. 84
Figure 6-1: Total Coronary Stent Units Sold by Segment, Europe, 2007 – 2017 .. 87
Figure 6-2: Total Coronary Stent ASP by Segment, Europe 2007 – 2017 (euro) . 88
Figure 6-3: Total Coronary Stent ASP by Segment, Europe 2007 – 2017 (US$) .. 88
Figure 6-4: Total Coronary Stent Market by Segment, Europe, 2007 – 2017 (euroM) 89
Figure 6-5: Total Coronary Stent Market by Segment, Europe, 2007 – 2017
(US$M) 89
Figure 6-6: Total Coronary Stent Market, Europe, 2007 – 2017 (euro) .. 94
Figure 6-7: Total Coronary Stent Market, Europe, 2007 – 2017 (US$) .. 94
Figure 6-8: Total Coronary Stent Units Sold by Country, Europe, 2007 – 2017 96
Figure 6-9: Total Coronary Stent ASP by Country, Europe, 2007 – 2017 (euro). 97
Figure 6-10: Total Coronary Stent ASP by Country, Europe, 2007 – 2017 (US$) 98
Figure 6-11: Total Coronary Stent Market by Country, Europe, 2007 – 2017
(euroM).. 99
Figure 6-12: Total Coronary Stent Market by Country, Europe, 2007 – 2017
(US$M) . 100
Figure 6-13: Drug-Eluting Stent Market, Europe, 2007 – 2017 (euro).. 102
Figure 6-14: Drug-Eluting Stent Market, Europe, 2007 – 2017 (US$) . 102
Figure 6-15: Drug-Eluting Stent Units Sold by Country, Europe, 2007 – 2017 .. 104
Figure 6-16: Drug-Eluting Stent ASP by Country, Europe, 2007 – 2017 (euro) . 105
Figure 6-17: Drug-Eluting Stent ASP by Country, Europe, 2007 – 2017 (US$) . 106
Figure 6-18: Drug-Eluting Stent Market by Country, Europe, 2007 – 2017
(euroM) 107
Figure 6-19: Drug-Eluting Stent Market by Country, Europe, 2007 – 2017
(US$M) . 108
Figure 6-20: Bare-Metal Stent Market, Europe, 2007 – 2017 (euro).. 110
Figure 6-21: Bare-Metal Stent Market, Europe, 2007 – 2017 (US$) . 110
Figure 6-22: Bare-Metal Stent Units Sold by Country, Europe, 2007 – 2017 .. 112
Figure 6-23: Bare-Metal Stent ASP by Country, Europe, 2007 – 2017 (euro) . 113
Figure 6-24: Bare-Metal Stent ASP by Country, Europe, 2007 – 2017 (US$) . 114
Figure 6-25: Bare-Metal Stent Market by Country, Europe, 2007 – 2017 (euroM).. 115
Figure 6-26: Bare-Metal Stent Market by Country, Europe, 2007 – 2017
(US$M) . 116
Figure 6-27: Drivers and Limiters, Drug-Eluting Stent Market, Europe, 2010 . 119
Figure 6-28: Drivers and Limiters, Bare-Metal Stent Market, Europe, 2010 120
Figure 6-29: Leading Competitors, Drug-Eluting Stent Market, Europe, 2010 124
Figure 6-30: Leading Competitors, Bare-Metal Stent Market, Europe, 2010 126
Figure 6-31: Potential Market for Bioabsorbable Stents, Europe, 2010 – 2017
(euro) 131
Figure 6-32: Potential Market for Bioabsorbable Stents, Europe, 2010 – 2017
(US$) . 132
Figure 6-33: Bifurcated Coronary Stent Market, Europe, 2010 – 2017 (euro) 135
Figure 6-34: Bifurcated Coronary Stent Market, Europe, 2010 – 2017 (US$) . 135
PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY
BALLOON CATHETER MARKET.. 137
Figure 7-1: PTCA Balloon Catheter Market, Europe, 2007 – 2017 (euro) .. 140
Figure 7-2: PTCA Balloon Catheter Market, Europe, 2007 – 2017 (US$). 140
Figure 7-3: PTCA Balloon Catheter Units Sold by Country, Europe,
2007 – 2017. 142
Figure 7-4: PTCA Balloon Catheter ASP by Country, Europe, 2007 – 2017 (euro) . 143
Figure 7-5: PTCA Balloon Catheter ASP by Country, Europe, 2007 – 2017
(US$) . 144
Figure 7-6: PTCA Balloon Catheter Market by Country, Europe, 2007 – 2017
(euroM) 145
Figure 7-7: PTCA Balloon Catheter Market by Country, Europe, 2007 – 2017
(US$M) . 146
Figure 7-8: Units Used Per Procedure, PTCA Balloon Catheter Market, Europe,
2007 – 2017. 147
Figure 7-9: Percentage of Units Sold by Indication, PTCA Balloon Catheter
Market, Europe, 2007 – 2017 .. 148
Figure 7-10: Percentage of Units Sold by Indication, PTCA Balloon Catheter
Market, Europe, 2007 – 2017 .. 149
Figure 7-11: Total Procedures, PTCA Balloon Catheter Market, Europe,
2007 – 2017. 150
Figure 7-12: Drivers and Limiters, PTCA Balloon Catheter Market, Europe,
2010 152
Figure 7-13 Leading Competitors, PTCA Balloon Catheter Market, Europe,
2010 154
INTERVENTIONAL CORONARY CATHETER MARKET 156
Figure 8-1: Units Per Procedure, Interventional Coronary Catheter Market,
Europe, 2007 – 2017 157
Figure 8-2: Interventional Coronary Catheter Market, Europe, 2007 – 2017 (euro) . 159
Figure 8-3: Interventional Coronary Catheter Market, Europe, 2007 – 2017
(US$) . 159
Figure 8-4: Interventional Coronary Catheter Units Sold by Country, Europe,
2007 – 2017. 161
Figure 8-5: Interventional Coronary Catheter ASP by Country, Europe,
2007 – 2017 (euro) . 162
Figure 8-6: Interventional Coronary Catheter ASP by Country, Europe,
2007 – 2017 (US$) 163
Figure 8-7: Interventional Coronary Catheter Market by Country, Europe,
2007 – 2017 (euroM) . 164
Figure 8-8: Interventional Catheter Market by Country, Europe, 2007 – 2017
(US$M) . 165
Figure 8-9: Drivers and Limiters, Interventional Coronary Catheter Market,
2010 167
Figure 8-10: Leading Competitors, Interventional Coronary Catheter Market,
Europe, 2010 .. 170
INTERVENTIONAL CORONARY GUIDEWIRE MARKET.. 172
Figure 9-1: Units Used per Procedure, Interventional Coronary Guidewire
Market, Europe, 2007 – 2017 .. 173
Figure 9-2: Interventional Coronary Guidewire Market, Europe, 2007 – 2017
(euro) 175
Figure 9-3: Interventional Coronary Guidewire Market, Europe, 2007 – 2017
(US$) . 175
Figure 9-4: Interventional Coronary Guidewire Units Sold by Country, Europe,
2007 – 2017. 177
Figure 9-5: Interventional Coronary Guidewire ASP by Country, Europe,
2007 – 2017 (euro) . 178
Figure 9-6: Interventional Coronary Guidewire ASP by Country, Europe,
2007 – 2017 (US$) 179
Figure 9-7: Interventional Coronary Guidewire Market by Country, Europe,
2007 – 2017 (euroM) . 180
Figure 9-8: Interventional Coronary Guidewire Market by Country, Europe,
2007 – 2017 (US$M) .. 181
Figure 9-9: Drivers and Limiters, Interventional Coronary Guidewire Market,
Europe, 2010 .. 183
Figure 9-10: Leading Competitors, Interventional Coronary Guidewire Market,
Europe, 2010 .. 186
CORONARY INTRODUCER SHEATH MARKET . 188
Figure 10-1: Units Sold by Segment, Coronary Introducer Sheath Market,
Europe, 2007 – 2017 190
Figure 10-2: Coronary Introducer Sheath ASP by Segment, Europe, 2007 – 2017
(euro) 191
Figure 10-3: Coronary Introducer Sheath ASP by Segment, Europe, 2007 – 2017
(US$) . 191
Figure 10-4: Total Coronary Introducer Sheath Market by Segment, Europe,
2007 – 2017 (euroM) . 192
Figure 10-5: Total Coronary Introducer Sheath Market by Segment, Europe,
2007 – 2017 (US$M) .. 192
Figure 10-6: Units per Procedure, Coronary Introducer Sheath Market, Europe,
2007 – 2017. 196
Figure 10-7: Coronary Introducer Sheath Market by Access Site, Europe,
2007 – 2017. 198
Figure 10-8: Total Coronary Introducer Sheath Market, Europe, 2007 – 2017 (euro)201
Figure 10-9: Total Coronary Introducer Sheath Market, Europe, 2007 – 2017
(US$) . 201
Figure 10-10: Total Coronary Introducer Sheath Units Sold by Country, Europe,
2007 – 2017. 203
Figure 10-11: Coronary Introducer Sheath ASP by Country, Europe, 2007 – 2017
(euro) 204
Figure 10-12: Coronary Introducer Sheath ASP by Country, Europe, 2007 – 2017
(US$) . 205
Figure 10-13: Coronary Introducer Sheath Market by Country, Europe,
2007 – 2017 (euroM) . 206
Figure 10-14: Coronary Introducer Sheath Market by Country, Europe,
2007 – 2017 (US$M) .. 207
Figure 10-15: Standard Coronary Introducer Sheath Market, Europe,
2007 – 2017 (euro) . 209
Figure 10-16: Standard Coronary Introducer Sheath Market, Europe,
2007 – 2017 (US$) 209
Figure 10-17: Standard Coronary Introducer Sheath Units Sold by Country,
Europe, 2007 – 2017 211
Figure 10-18: Standard Introducer Sheath ASP by Country, Europe, 2007 – 2017
(euro) 212
Figure 10-19: Standard Introducer Sheath ASP by Country, Europe, 2007 – 2017
(US$) . 213
Figure 10-20: Standard Introducer Sheath Market by Country, Europe,
2007 – 2017 (euroM) . 214
Figure 10-21: Standard Introducer Sheath Market by Country, Europe,
2007 – 2017 (US$M) .. 215
Figure 10-22: Coronary Micro-Introducer Sheath Market, Europe, 2007 – 2017
(euro) 217
Figure 10-23: Coronary Micro-Introducer Sheath Market, Europe, 2007 – 2017
(US$) . 217
Figure 10-24: Coronary Micro-Introducer Sheath Units Sold by Country, Europe,
2007 – 2017. 219
Figure 10-25: Coronary Micro-Introducer Sheath ASP by Country, Europe,
2007 – 2017 (euro) . 220
Figure 10-26: Coronary Micro-Introducer Sheath ASP by Country, Europe,
2007 – 2017 (US$) 221
Figure 10-27: Coronary Micro-Introducer Sheath Market by Country, Europe,
2007 – 2017 (euroM) . 222
Figure 10-28: Coronary Micro-Introducer Sheath Market by Country, Europe,
2007 – 2017 (US$M) .. 223
Figure 10-29: Drivers and Limiters, Coronary Introducer Sheath Market,
Europe, 2010 .. 225
Figure 10-30: Leading Competitors, Coronary Introducer Sheath Market, Europe,
2010 .. 227
CORONARY EMBOLIC PROTECTION DEVICE MARKET. 229
Figure 11-1: Coronary Embolic Protection Device Market, Europe, 2007 – 2017
(euro) 232
Figure 11-2: Coronary Embolic Protection Device Market, Europe, 2007 – 2017
(US$) . 232
Figure 11-3 Coronary Embolic Protection Device Units Sold by Country,
Europe, 2007 – 2017 234
Figure 11-4: Coronary Embolic Protection Device ASP by Country, Europe,
2007 – 2017 (euro) . 235
Figure 11-5: Coronary Embolic Protection Device ASP by Country, Europe,
2007 – 2017 (US$) 236
Figure 11-6: Coronary Embolic Protection Device Market by Country, Europe,
2007 – 2017 (euroM) . 237
Figure 11-7: Coronary Embolic Protection Device Market by Country, Europe,
2007 – 2017 (US$M) .. 238
Figure 11-8: Penetration Rate for Angioplasties, Coronary Embolic Protection
Device Market, Europe, 2007 – 2017 239
Figure 11-9: Drivers and Limiters, Coronary Embolic Protection Device Market,
Europe, 2010 .. 241
Figure 11-10: Leading Competitors, Coronary Embolic Protection Device Market,
Europe, 2010 .. 243
CORONARY ATHERECTOMY DEVICE MARKET . 245
Figure 12-1: Total Coronary Atherectomy Device Market, Europe, 2007 – 2017
(euro) 248
Figure 12-2: Total Coronary Atherectomy Device Market, Europe, 2007 – 2017
(US$) . 248
Figure 12-3: Coronary Atherectomy Device Units Sold by Country, Europe,
2007 – 2017. 250
Figure 12-4: Coronary Atherectomy Device ASP by Country, Europe,
2007 – 2017 (euro) . 251
Figure 12-5: Coronary Atherectomy Device ASP by Country, Europe,
2007 – 2017 (US$) 252
Figure 12-6: Coronary Atherectomy Device Market by Country, Europe,
2007 – 2017 (euroM) . 253
Figure 12-7: Coronary Atherectomy Device Market by Country, Europe,
2007 – 2017 (US$M) .. 254
Figure 12-8: Drivers and Limiters, Coronary Atherectomy Device Market, Europe
2010 256
Figure 12-9: LeadingCompetitors, Coronary Atherectomy Device Market,
Europe, 2010 .. 258
DIAGNOSTIC CORONARY CATHETER AND GUIDEWIRE MARKET 260
Figure 13-1: Units per Procedure, Diagnostic Coronary Catheter and Guidewire
Market, Europe, 2007 – 2017 .. 262
Figure 13-2: Units Sold, Diagnostic Coronary Catheter and Guidewire Market,
Europe, 2007 – 2017 262
Figure 13-3: Diagnostic Coronary Catheter and Guidewire ASP by Segment,
Europe 2007 – 2017 (euro) . 263
Figure 13-4: Diagnostic Coronary Catheter and Guidewire ASP by Segment,
Europe 2007 – 2017 (US$) 263
Figure 13-5: Diagnostic Coronary Catheter and Guidewire Market by Segment,
Europe, 2007 – 2017 (euroM) 264
Figure 13-6: Diagnostic Coronary Catheter and Guidewire Market by Segment,
Europe, 2007 – 2017 (US$M).. 264
Figure 13-7: Total Diagnostic Catheter and Guidewire Market, Europe,
2007 – 2017 (euro) . 269
Figure 13-8: Total Diagnostic Catheter and Guidewire Market, Europe,
2007 – 2017 (US$) 269
Figure 13-9: Diagnostic Catheter and Guidewire Units Sold by Country, Europe,
2007 – 2017. 270
Figure 13-10: Diagnostic Catheter and Guidewire ASP by Country, Europe,
2007 – 2017 (euro) . 271
Figure 13-11: Diagnostic Catheter and Guidewire ASP by Country, Europe,
2007 – 2017 (US$) 272
Figure 13-12: Diagnostic Catheter and Guidewire Market by Country, Europe,
2007 – 2017 (euroM) . 273
Figure 13-13: Diagnostic Catheter and Guidewire Market by Country, Europe,
2007 – 2017 (US$M) .. 274
Figure 13-14: Diagnostic Catheter Market, Europe, 2007 – 2017 (euro).. 276
Figure 13-15: Diagnostic Catheter Market, Europe, 2007 – 2017 (US$) . 276
Figure 13-16: Diagnostic Catheter Units Sold by Country, Europe,
2007 – 2017. 278
Figure 13-17: Diagnostic Catheter ASP by Country, Europe, 2007 – 2017 (euro). 279
Figure 13-18: Diagnostic Catheter ASP by Country, Europe, 2007 – 2017 (US$) 280
Figure 13-19: Diagnostic Catheter Market by Country, Europe, 2007 – 2017
(euroM) 281
Figure 13-20: Diagnostic Catheter Market by Country, Europe, 2007 – 2017
(US$M) . 282
Figure 13-21: Diagnostic Guidewire Market, Europe, 2007 – 2017 (euro) 284
Figure 13-22: Diagnostic Guidewire Market, Europe, 2007 – 2017 (US$) . 284
Figure 13-23: Diagnostic Guidewire Units Sold by Country, Europe,
2007 – 2017. 286
Figure 13-24: Diagnostic Guidewire ASP by Country, Europe, 2007 – 2017 (euro). 287
Figure 13-25: Diagnostic Guidewire ASP by Country, Europe, 2007 – 2017
(US$) . 288
Figure 13-26: Diagnostic Guidewire Market by Country, Europe, 2007 – 2017
(euroM) 289
Figure 13-27: Diagnostic Guidewire Market by Country, Europe, 2007 – 2017
(US$M) . 290
Figure 13-28: Drivers and Limiters, Diagnostic Catheter and Guidewire Market,
Europe, 2010 .. 292
Figure 13-29: Leading Competitors, Diagnostic Catheter and Guidewire Market,
Europe, 2010 .. 294
FRACTIONAL FLOW RESERVE GUIDEWIRE MARKET 298
Figure 14-1: Fractional Flow Reserve Guidewire Market, Europe, 2007 – 2017
(euro) 300
Figure 14-2: Fractional Flow Reserve Guidewire, Europe, 2007 – 2017 (US$) .. 300
Figure 14-3: Fractional Flow Reserve Guidewire Units Sold by Country, Europe,
2007 – 2017. 302
Figure 14-4: Fractional Flow Reserve Guidewire ASP by Country, Europe,
2007 – 2017 (euro) . 303
Figure 14-5: Fractional Flow Reserve Guidewire ASP by Country, Europe,
2007 – 2017 (US$) 304
Figure 14-6: Fractional Flow Reserve Guidewire Market by Country, Europe,
2007 – 2017 (euroM) . 305
Figure 14-7: Fractional Flow Reserve Guidewire Market by Country, Europe,
2007 – 2017 (US$M) .. 306
Figure 14-8: Drivers and Limiters, Fractional Flow Reserve Guidewire Market,
Europe, 2007 – 2017 308
Figure 14-9: Leading Competitors, Fractional Flow Reserve Guidewire Market,
Europe, 2010 .. 309
CORONARY VASCULAR CLOSURE DEVICE MARKET. 311
Figure 15-1: Total Coronary VCD Units Sold by Segment, Europe,
2007 – 2017. 313
Figure 15-2: Total Coronary VCD ASP by Segment, Europe 2007 – 2017 (euro) 313
Figure 15-3: Total Coronary VCD ASP by Segment, Europe 2007 – 2017
(US$) . 314
Figure 15-4: Total Coronary VCD Device Market by Segment, Europe,
2007 – 2017 (euroM) . 314
Figure 15-5: Total Coronary VCD Market by Segment, Europe, 2007 – 2017
(US$M) . 315
Figure 15-6: Total Coronary VCD Market, Europe, 2007 – 2017 (euro) .. 320
Figure 15-7: Total Coronary VCD Market, Europe, 2007 – 2017 (US$) 320
Figure 15-8 Total Coronary VCD Units Sold by Country, Europe, 2007 – 2017 322
Figure 15-9 Total Coronary VCD ASP by Country, Europe, 2007 – 2017 (euro) . 323
Figure 15-10: Total Coronary VCD ASP by Country, Europe, 2007 – 2017
(US$) . 324
Figure 15-11: Total Coronary VCD Market by Country, Europe, 2007 – 2017
(euroM) 325
Figure 15-12: Total Coronary VCD Market by Country, Europe, 2007 – 2017
(US$M) . 326
Figure 15-13: Total Coronary VCD Market by Access Site, Europe,
2007 – 2017. 327
Figure 15-14: Invasive Coronary VCD Market, Europe, 2007 – 2017 (euro) . 330
Figure 15-15: Invasive Coronary VCD Market, Europe, 2007 – 2017 (US$) .. 330
Figure 15-16 Invasive Coronary VCD Units Sold by Country, Europe,
2007 – 2017. 332
Figure 15-17 Invasive Coronary VCD ASP by Country, Europe, 2007 – 2017
(euro) 333
Figure 15-18: Invasive Coronary VCD ASP by Country, Europe, 2007 – 2017
(US$) . 334
Figure 15-19: Invasive Coronary VCD Market by Country, Europe, 2007 – 2017
(euroM) 335
Figure 15-20: Invasive Coronary VCD Market by Country, Europe, 2007 – 2017
(US$M) . 336
Figure 15-21: Non-Invasive Coronary VCD Market, Europe, 2007 – 2017 (euro) 338
Figure 15-22: Non-Invasive Coronary VCD Market, Europe, 2007 – 2017 (US$)338
Figure 15-23 Non-Invasive Coronary VCD Units Sold by Country, Europe,
2007 – 2017. 340
Figure 15-24 Non-Invasive Coronary VCD ASP by Country, Europe,
2007 – 2017 (euro) . 341
Figure 15-25: Non-Invasive Coronary VCD ASP by Country, Europe,
2007 – 2017 (US$) 342
Figure 15-26: Non-Invasive Coronary VCD Market by Country, Europe,
2007 – 2017 (euroM) . 343
Figure 15-27: Non-Invasive Coronary VCD Market by Country, Europe,
2007 – 2017 (US$M) .. 344
Figure 15-28: Drivers and Limiters, Coronary VCD Market, Europe, 2010 .. 346
Figure 15-29: Leading Competitors, Coronary VCD Market, Europe, 2010 . 349
INTRAVASCULAR ULTRASOUND CATHETER MARKET 351
Figure 16-1: IVUS Catheter Market, Europe, 2007 – 2017 (euro) 354
Figure 16-2: IVUS Catheter Market, Europe, 2007 – 2017 (US$) . 354
Figure 16-3: IVUS Catheter Units Sold by Country, Europe, 2007 – 2017 356
Figure 16-4: IVUS Catheter ASP by Country, Europe, 2007 – 2017 (euro) . 357
Figure 16-5: IVUS Catheter ASP by Country, Europe, 2007 – 2017 (US$) 358
Figure 16-6: IVUS Catheter Market by Country, Europe, 2007 – 2017 (euroM) 359
Figure 16-7: IVUS Catheter Market by Country, Europe, 2007 – 2017 (US$M) . 360
Figure 16-8: Penetration Rate, IVUS Catheter Market, Europe, 2007 – 2017 361
Figure 16-9: Market Drivers and Limiters, IVUS Catheter Market, Europe,
2010 363
Figure 16-10: Leading Competitors, IVUS Catheter Market, Europe, 2010 .. 365
OPTICAL COHERENCE TOMOGRAPHY CATHETER MARKET. 367
Figure 17-1: OCT Catheter Market, Europe, 2007 – 2017 (euro) . 371
Figure 17-2: OCT Catheter Market, Europe, 2007 – 2017 (US$) 371
Figure 17-3: OCT Catheter Units Sold by Country, Europe, 2007 – 2015.. 373
Figure 17-4: OCT Catheter ASP by Country, Europe, 2007 – 2015 (euro) 374
Figure 17-5: OCT Catheter ASP by Country, Europe, 2007 – 2015 (US$) . 375
Figure 17-6: OCT Catheter Market by Country, Europe, 2007 – 2015 (euroM) . 376
Figure 17-7: OCT Catheter Market by Country, Europe, 2007 – 2015 (US$M) 377
Figure 17-8: Penetration Rate, OCT Catheter Market, Europe, 2007 – 2017. 378
Figure 17-9: Drivers and Limiters, OCT Catheter Market, Europe, 2010 380
Figure 17-10: Leading Competitors, OCT Catheter Market, Europe, 2010. 382
VULNERABLE PLAQUE DEVICE MARKET.. 383
Figure 18-1: Target Population, Potential Market for Vulnerable Plaque, Europe,
2007 – 2017. 389
Figure 18-2: Maximum Potential Market for Vulnerable Plaque, Europe,
2010 – 2017 (euroM) . 392
Figure 18-3: Maximum Potential Market for Vulnerable Plaque, Europe,
2010 – 2017 (US$M) .. 392
Figure 18-4: Potential Market for Vulnerable Plaque Screening, Europe,
2010 – 2017 (euro) . 396
Figure 18-5: Potential Market for Vulnerable Plaque Screening, Europe,
2010 – 2017 (US$) 397
Figure 18-6: Potential Market for Vulnerable Plaque Treatment, Europe,
2013 – 2017 (euro) . 400
Figure 18-7: Potential Market for Vulnerable Plaque Treatment, Europe,
2013 – 2017 (US$) 401
Figure 18-8: Drivers and Limiters, Vulnerable Plaque Device Market, Europe,
2010 403
Figure 18-9: Potential Competitors, Vulnerable Plaque Device Market, Europe,
2010 – 2017. 408
ABBREVIATIONS 409
LIST OF CHARTS
EXECUTIVE SUMMARY 1
Chart 1-1: Interventional Cardiology Device Market, Europe, 2007 – 2017 (euroM) 1
Chart 1-2: Fastest Growing Interventional Cardiology Markets by Country, 2007
– 2017 . 2
Chart 1-3: Angioplasty Procedures, Europe, 2007 – 2017 .. 3
Chart 1-4: Country Statistics, Portugal, 2010 . 5
Chart 1-5: Coronary Stent Market, Europe, 2007 – 2017 (euroM). 6
Chart 1-6: Coronary Atherectomy Device Market, Europe, 2007 – 2017 (euroM).. 9
Chart 1-7: Diagnostic Coronary Catheter and Guidewire Market, Europe,
2007 – 2017 (euroM) 10
Chart 1-8: Coronary VCD Market, Europe, 2010 – 2017 (euroM). 12
Chart 1-9: Optical Coherence Tomography Device Market, Europe, 2010 – 2017
(euroM).. 13
Chart 1-10: Leading Competitors, Interventional Cardiology Markets, Europe,
2010 .. 15
RESEARCH METHODOLOGY.. 16
EUROPEAN INTERVENTIONAL CARDIOLOGY DEVICE MARKETS 28
Chart 3-1: Interventional Cardiology Device Markets, Europe, 2007 – 2017 (euroM) 33
Chart 3-2: Interventional Cardiology Device Markets Segmented by Device
Type, Europe, 2010. 39
Chart 3-3: Interventional Cardiology Device M
To order this report:
: European Markets for Interventional Cardiology Devices 2011 (15 Countries)
Check our Company Profile, SWOT and Revenue Analysis!
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
Share this article